Skip to content

Compatibility test of two skin care creams for the care of patients with atopic dermatitis

Compatibility test of two skin care creams for the care of patients with atopic dermatitis - SmartOx2

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00028916
Enrollment
30
Registered
2022-06-24
Start date
2022-12-14
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atopic dermatitis

Interventions

Group 1: Study of skin tolerance of the cream formulation: the cream without preservatives is better tolerated. Group 2: It will be shown that the submicrostructured formulation works better than the

Sponsors

Charité-Universitätsmedizin Berlin, Dermatologie
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria: - The studies will be conducted on study participants who are - suffer from atopic dermatitis - are 18 to 70 years old - are informed about the aims of the study and the nature of the investigations - have given their written informed consent to participate - have given their written consent.

Exclusion criteria

Exclusion criteria: Exclusion Criteria: Excluded are: - Patients who regularly used or took antibiotics, steroids, or tacrolimus treatments; in the 2 weeks prior to enrollment - Patients with severely infected lesions requiring oral or intravenous antibiotics; and Auxiliary therapy; - Patients with dermatologic diagnoses other than AD; - Use of systemic immunosuppressive medications prior (at least 4 weeks) to the study and/or expected use during the study; - Individuals with allergies or intolerant - reactions to food - Pregnant women and nursing mothers - Individuals who have not given written informed consent - have not given their written informed consent - Persons who are not able to make - make decisions on their own responsibility - Students of the Charité in the semester of examination

Design outcomes

Primary

MeasureTime frame
Endpoints for cream with preservative: score from itching, skin hydration and skin barrier.

Secondary

MeasureTime frame
Endpoints for cream from the dispenser: score from itching, skin hydration and skin barrier.

Countries

Germany

Contacts

Public ContactMartina Meinke

Charité-Universitätsmedizin Berlin, Dermatologie

martina.meinke@charite.de030450518244

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026